Investigating umbilical cord reduction in the treatment of constipation in patients with type 2 diabetes

Investigating the effect of umbilical reduction technique in the treatment of chronic constipation in patients with type 2 diabetes with symptoms of Umbilical displacement: a clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240212060967N1

Enrollment

Registered

2024-04-13

Start date

2024-05-04

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Type 2 diabetes. Condition 2: constipation. Type 2 diabetes mellitus with unspecified complications Functional intestinal disorder, unspecified

Interventions

Intervention 1: Intervention group: Umbilical reduction is performed(The thumb is placed inside the navel and a 360-degree rotation is performed in the navel area. The starting point of the rotation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes with umbilical displacement and chronic constipation Based on the Cleveland criteria Free and informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: The presence of large or multiple scars that disturb the examination of the abdomen Umbilical hernia endometriosis a history of cancer, severe enteritis, intestinal obstruction, inflammatory bowel disease, hypothyroidism, mental illness, stroke, heart disease, liver cirrhosis, renal failure, endometriosis, hematopoietic system diseases, or organic intestinal diseases indicated by colonoscopy or imaging display Addiction to drugs or sleeping pills Pregnancy of referring women Abdominal surgery within the last six months Daily use of laxatives other health issues that make them unsuitable to participate.

Design outcomes

Primary

Measure	Time frame
Constipation. Timepoint: At the beginning of the study and after six weeks. Method of measurement: Cleveland Questionnaire.	—

Secondary

Measure	Time frame
Fasting blood sugar. Timepoint: The beginning of the study and the end of the study. Method of measurement: Laboratory test.;2 hours post prandial blood sugar. Timepoint: The beginning of the study and the end of the study. Method of measurement: Laboratory test.;Hemoglobin A1C. Timepoint: The beginning of the study and the end of the study. Method of measurement: Laboratory test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeedeh Kargar Shoroki

Yazd University of Medical Sciences

Saeedeh.kargar1983@gmail.com+98 35 3223 8918

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026